Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic pulses aim to ease nerve pain without drugs

NCT ID NCT07705490

Symptom relief Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial investigates whether high-intensity peripheral magnetic stimulation can reduce pain and improve function in adults with traumatic peripheral nerve injury. Participants receive either active or sham magnetic stimulation alongside a standard exercise program. The study measures changes in pain, nerve function, and quality of life over 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-Intensity Peripheral Magnetic Stimulation (PMS) delivered via a coil over the injured nerve, 3 times per week for 3 weeks.
What this could lead to
If it works, this could offer a non-invasive, drug-free way to ease chronic nerve pain and improve muscle function after traumatic nerve injury.
What could go wrong
This is a small, early-stage trial with only 40 participants. The sham control may show similar effects, and results may not apply to all nerve injuries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 65 years * Traumatic peripheral nerve injury * Unilateral traumatic peripheral neuropathy confirmed by electromyography (EMG) * Nerve injury occurring at least 3 months prior * Douleur Neuropathique 4 (DN4) score ≥ 4 * Visual Analog Scale (VAS) score ≥ 4 * Manual Muscle Testing score \< 5 * No analgesic use, or stable analgesic therapy for the past month (no dose changes) Exclusion Criteria: * Active infection or malignancy * Metal implant or shrapnel in the application area * Electronic implants (e.g., cardiac pacemaker, spinal cord stimulator, deep brain stimulator) * Central nervous system diseases * Non-traumatic causes of neuropathy (e.g., radiculopathy, diabetic neuropathy, entrapment neuropathies, HIV-related neuropathy, trigeminal neuralgia) * Complete nerve injury * Injury involving three or more peripheral nerves or plexus injury * History of peripheral nerve surgery or injection within the past 3 months * Active psychiatric illness * Coagulopathy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuropathic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuralgia Peripheral Nerve Injuries traumatic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuropathic pain Peripheral nerve injuries Peripheral nerve injuries, traumatic Traumatic peripheral nerve injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

    Ankara, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.